Health condition
Fibrolamellar liver cancer
Fibrolamellar carcinoma is a rare liver cancer of teenagers and young adults with healthy livers, defined by a unique DNAJB1-PRKACA gene fusion; aggressive surgery - including repeat resection - is the mainstay, and specialist review is essential.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
Affects young people without cirrhosis, hepatitis or other liver disease
-
Defined by the DNAJB1-PRKACA fusion, which confirms the diagnosis
-
Alpha-fetoprotein is typically normal - unlike conventional liver cancer
-
Surgery, including lymph node clearance and repeat operations for recurrence, drives survival
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
A liver tumour in a nineteen-year-old with no liver disease violates every usual pattern, and that is precisely fibrolamellar carcinoma’s profile: vague upper abdominal discomfort, early satiety or a palpable mass in someone young and otherwise well, with standard liver cancer blood markers unhelpfully normal. Imaging shows a large, often central mass with a fibrous scar, and molecular testing for the pathognomonic fusion settles what biopsy alone sometimes cannot.
Diagnosis and treatment routes
Management rewards surgical ambition within specialist hands: complete resection with regional lymphadenectomy offers the best outcome, and - unusually among cancers - returning to operate on recurrences meaningfully extends survival, so follow-up is intensive and long. Transplantation has a selective role. Systemic therapy remains an unsettled field where enrolment in fibrolamellar-specific trials and registries, an active international effort, is genuinely worthwhile for this small patient community. If you are waiting for results or want a second opinion on a proposed plan, a private consultation with a specialist who treats this condition regularly can usually be arranged quickly, and most will review your existing scans, biopsy reports and MDT correspondence.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant hepatobiliary surgeon. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Fibrolamellar liver cancer.
Quick, plain-English answers to what people ask us most.
-
What does fibrolamellar liver cancer mean?
Fibrolamellar liver cancer is a condition your doctor may diagnose based on your symptoms, medical history and, where needed, examination or test results. Understanding exactly how it applies to your situation is best done with a clinician who can look at your full picture rather than relying on general information alone.
-
What are the risk factors for fibrolamellar liver cancer?
Fibrolamellar liver cancer can arise from several different underlying mechanisms, and in many cases more than one factor contributes. Identifying likely causes usually forms part of the initial specialist work-up.
-
What are the symptoms of fibrolamellar liver cancer?
Symptoms of fibrolamellar liver cancer vary from person to person and can range from mild and easily missed to significant enough to affect daily life. Because overlapping conditions can produce similar symptoms, a clinical assessment is the most reliable way to confirm what's actually going on.
-
How dangerous is fibrolamellar liver cancer?
Fibrolamellar liver cancer is a serious diagnosis that needs prompt, specialist-led assessment and a clear treatment plan. Outcomes depend heavily on factors such as how early it's found and how it responds to treatment, which is why timely investigation matters.
-
Is fibrolamellar liver cancer hereditary?
In most cases fibrolamellar liver cancer isn't straightforwardly inherited, though family history can sometimes be a relevant background factor. A clinician can help you understand whether it's worth mentioning relatives' health when being assessed.
-
Is fibrolamellar liver cancer treatable?
Treatment for fibrolamellar liver cancer depends on the stage and type at diagnosis, and can include surgery, medical therapy, radiotherapy or a combination, sometimes with curative intent and sometimes focused on control and quality of life. A multidisciplinary specialist team is best placed to explain realistic goals for your specific case.
-
How is fibrolamellar liver cancer treated?
Treatment for fibrolamellar liver cancer is usually built around the severity of your symptoms and any underlying cause found on assessment, and may involve lifestyle measures, medication, physiotherapy or, in some cases, a procedure. Your specialist will discuss the pros and cons of each option with you before agreeing a plan.
-
What's the outlook for fibrolamellar liver cancer?
The outlook for fibrolamellar liver cancer varies widely depending on the underlying cause, how early it's diagnosed, and how it responds to treatment. Many people see significant improvement with appropriate care, and your specialist can give you a more personalised timeframe once they've reviewed your case.
-
When is surgery needed for fibrolamellar liver cancer?
Whether surgery plays a role in treating fibrolamellar liver cancer depends on factors such as stage, location and overall health, and is decided by a multidisciplinary team weighing up the likely benefits against the risks. Non-surgical options are often used alongside or instead of surgery depending on the individual case.
-
When should I see a doctor about fibrolamellar liver cancer, and how quickly can I be seen privately?
It's worth seeking medical advice if symptoms of fibrolamellar liver cancer are persistent, worsening, or affecting your daily life, rather than waiting for them to resolve on their own. NHS routine referrals for this kind of assessment can take anywhere from around 20 to 45+ weeks, whereas private consultants typically offer an appointment within about two weeks.